03:48 AM EST, 12/04/2025 (MT Newswires) -- Joseph K Belanoff, Director, Chief Executive Officer, on December 01, 2025, sold 40,000 shares in Corcept Therapeutics ( CORT ) for $3,190,796. Following the Form 4 filing with the SEC, Belanoff has control over a total of 2,701,370 common shares of the company, with 2,701,370 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000119312525307204/xslF345X05/ownership.xml